In orthopaedics, Johnson & Johnson MedTech focuses on joint reconstruction, robotics, spine, sports, trauma, and extremities. Credit: Ahmet Misirligul / Shutterstock.

Johnson & Johnson MedTech has announced an exclusive commercial distribution agreement in the US with Responsive Arthroscopy for expanding sports soft tissue repair solutions.

This collaboration aims to strengthen Johnson & Johnson MedTech’s sports platform and will deliver advanced soft tissue repair solutions for foot, shoulder and ankle procedures.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It will enhance Johnson & Johnson MedTech’s soft tissue portfolio to meet the growing demand for advanced solutions in the market.

This agreement will see the combination of Johnson & Johnson MedTech’s knowledge in orthopaedic innovation with the advanced technologies of responsive arthroscopy to provide a comprehensive set of tools to healthcare providers for addressing evolving needs.

Johnson & Johnson MedTech Orthopaedics company group chairman Aldo Denti said “Our relationship with Responsive Arthroscopy is a significant step in expanding our leadership in orthopaedics and advancing our sports soft tissue offerings.

“This collaboration allows us to deliver a broader range of cutting-edge tools that empower surgeons in shoulder, foot and ankle procedures. We’re excited to drive value in this rapidly growing segment and remain committed to advancing patient care in meaningful ways.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

In orthopaedics, the company focuses on robotics, joint reconstruction, spine, sports, trauma, and extremities, leveraging deep expertise to develop next-generation medical technology solutions.

This month, after years of teasing an entry into the surgical robotics space, Johnson & Johnson MedTech completed a major step in progressing its system, winning an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) for the technology.

The IDE will allow the company to conduct clinical trials at US sites with the robotic surgical system called Ottava.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact